Cannabidiol Extract Market Analysis

Cannabidiol extract market from the pharmaceutical application segment was valued at over USD 3 billion in 2022 and is expected to show notable growth between 2023 and 2032. The pharmaceutical segment is further divided into tablets & capsules, transdermal patches, creams & roll-ons, suppository, and others. Increasing adoption of CBD extracts in the pharmaceutical sector owing to its varied advantages in the treatment of joint pain & inflammation, seizures, sleep/insomnia, and neurological conditions, among others is foreseen to impel segment uptake.
 

Cannabidiol extract market share from the marijuana segment is speculated to exceed USD 9.5 billion by 2032 bolstered by mounting applications of marijuana-based CBD products for pain relief, depression, and for the treatment of Alzheimer’s disease, dementia, neuropathic pain, and other brain-related illnesses. Moreover, supportive government efforts to legalize marijuana usage, especially for medicinal purposes, are slated to facilitate segment adoption.
 

North America CBD extract market was worth more than USD 3 billion in 2022 and is projected to exhibit steady progress over the forecast period. Surging adoption of marijuana for medical utilization, such as for managing pain, inflammation, anxiety, and stress among the adult population in the region is likely to boost product sales. Furthermore, prominent focus of government and health agencies viz. the U.S. FDA on research efforts pertaining to CBD and its applications is anticipated to be favorable for the regional industry scenario.